Report Detail

Pharma & Healthcare Global Aciclovir Market Research Report 2021

  • RnM4300899
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 131 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Aciclovir Market Overview

  • 1.1 Product Overview and Scope of Aciclovir
  • 1.2 Aciclovir Segment by Type
    • 1.2.1 Global Aciclovir Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Generic
    • 1.2.3 Patent
  • 1.3 Aciclovir Segment by Application
    • 1.3.1 Aciclovir Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Drug Store
  • 1.4 Global Aciclovir Market Size Estimates and Forecasts
    • 1.4.1 Global Aciclovir Revenue 2016-2027
    • 1.4.2 Global Aciclovir Sales 2016-2027
    • 1.4.3 Aciclovir Market Size by Region: 2016 Versus 2021 Versus 2027

2 Aciclovir Market Competition by Manufacturers

  • 2.1 Global Aciclovir Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Aciclovir Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Aciclovir Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Aciclovir Manufacturing Sites, Area Served, Product Type
  • 2.5 Aciclovir Market Competitive Situation and Trends
    • 2.5.1 Aciclovir Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Aciclovir Players Market Share by Revenue
    • 2.5.3 Global Aciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Aciclovir Retrospective Market Scenario by Region

  • 3.1 Global Aciclovir Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Aciclovir Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Aciclovir Market Facts & Figures by Country
    • 3.3.1 North America Aciclovir Sales by Country
    • 3.3.2 North America Aciclovir Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Aciclovir Market Facts & Figures by Country
    • 3.4.1 Europe Aciclovir Sales by Country
    • 3.4.2 Europe Aciclovir Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Aciclovir Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Aciclovir Sales by Region
    • 3.5.2 Asia Pacific Aciclovir Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Aciclovir Market Facts & Figures by Country
    • 3.6.1 Latin America Aciclovir Sales by Country
    • 3.6.2 Latin America Aciclovir Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Aciclovir Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Aciclovir Sales by Country
    • 3.7.2 Middle East and Africa Aciclovir Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Aciclovir Historic Market Analysis by Type

  • 4.1 Global Aciclovir Sales Market Share by Type (2016-2021)
  • 4.2 Global Aciclovir Revenue Market Share by Type (2016-2021)
  • 4.3 Global Aciclovir Price by Type (2016-2021)

5 Global Aciclovir Historic Market Analysis by Application

  • 5.1 Global Aciclovir Sales Market Share by Application (2016-2021)
  • 5.2 Global Aciclovir Revenue Market Share by Application (2016-2021)
  • 5.3 Global Aciclovir Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Greater Pharma
    • 6.1.1 Greater Pharma Corporation Information
    • 6.1.2 Greater Pharma Description and Business Overview
    • 6.1.3 Greater Pharma Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Greater Pharma Product Portfolio
    • 6.1.5 Greater Pharma Recent Developments/Updates
  • 6.2 LBS Labs
    • 6.2.1 LBS Labs Corporation Information
    • 6.2.2 LBS Labs Description and Business Overview
    • 6.2.3 LBS Labs Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 LBS Labs Product Portfolio
    • 6.2.5 LBS Labs Recent Developments/Updates
  • 6.3 GlaxoSmithKline
    • 6.3.1 GlaxoSmithKline Corporation Information
    • 6.3.2 GlaxoSmithKline Description and Business Overview
    • 6.3.3 GlaxoSmithKline Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 GlaxoSmithKline Product Portfolio
    • 6.3.5 GlaxoSmithKline Recent Developments/Updates
  • 6.4 Lex Ano
    • 6.4.1 Lex Ano Corporation Information
    • 6.4.2 Lex Ano Description and Business Overview
    • 6.4.3 Lex Ano Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Lex Ano Product Portfolio
    • 6.4.5 Lex Ano Recent Developments/Updates
  • 6.5 Salutas
    • 6.5.1 Salutas Corporation Information
    • 6.5.2 Salutas Description and Business Overview
    • 6.5.3 Salutas Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Salutas Product Portfolio
    • 6.5.5 Salutas Recent Developments/Updates
  • 6.6 Novartis
    • 6.6.1 Novartis Corporation Information
    • 6.6.2 Novartis Description and Business Overview
    • 6.6.3 Novartis Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Novartis Product Portfolio
    • 6.6.5 Novartis Recent Developments/Updates
  • 6.7 Teva
    • 6.6.1 Teva Corporation Information
    • 6.6.2 Teva Description and Business Overview
    • 6.6.3 Teva Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Teva Product Portfolio
    • 6.7.5 Teva Recent Developments/Updates
  • 6.8 Stada Nordic
    • 6.8.1 Stada Nordic Corporation Information
    • 6.8.2 Stada Nordic Description and Business Overview
    • 6.8.3 Stada Nordic Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Stada Nordic Product Portfolio
    • 6.8.5 Stada Nordic Recent Developments/Updates
  • 6.9 Cimed Industria de Medicamentos
    • 6.9.1 Cimed Industria de Medicamentos Corporation Information
    • 6.9.2 Cimed Industria de Medicamentos Description and Business Overview
    • 6.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Cimed Industria de Medicamentos Product Portfolio
    • 6.9.5 Cimed Industria de Medicamentos Recent Developments/Updates
  • 6.10 Reman Drug
    • 6.10.1 Reman Drug Corporation Information
    • 6.10.2 Reman Drug Description and Business Overview
    • 6.10.3 Reman Drug Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Reman Drug Product Portfolio
    • 6.10.5 Reman Drug Recent Developments/Updates
  • 6.11 L.E.T.I.
    • 6.11.1 L.E.T.I. Corporation Information
    • 6.11.2 L.E.T.I. Aciclovir Description and Business Overview
    • 6.11.3 L.E.T.I. Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 L.E.T.I. Product Portfolio
    • 6.11.5 L.E.T.I. Recent Developments/Updates
  • 6.12 Nichi-Iko Pharmaceutical
    • 6.12.1 Nichi-Iko Pharmaceutical Corporation Information
    • 6.12.2 Nichi-Iko Pharmaceutical Aciclovir Description and Business Overview
    • 6.12.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Nichi-Iko Pharmaceutical Product Portfolio
    • 6.12.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
  • 6.13 Choseido Pharmaceutical
    • 6.13.1 Choseido Pharmaceutical Corporation Information
    • 6.13.2 Choseido Pharmaceutical Aciclovir Description and Business Overview
    • 6.13.3 Choseido Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Choseido Pharmaceutical Product Portfolio
    • 6.13.5 Choseido Pharmaceutical Recent Developments/Updates
  • 6.14 Shiono Kemikaru
    • 6.14.1 Shiono Kemikaru Corporation Information
    • 6.14.2 Shiono Kemikaru Aciclovir Description and Business Overview
    • 6.14.3 Shiono Kemikaru Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Shiono Kemikaru Product Portfolio
    • 6.14.5 Shiono Kemikaru Recent Developments/Updates
  • 6.15 Towa Yakuhin
    • 6.15.1 Towa Yakuhin Corporation Information
    • 6.15.2 Towa Yakuhin Aciclovir Description and Business Overview
    • 6.15.3 Towa Yakuhin Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Towa Yakuhin Product Portfolio
    • 6.15.5 Towa Yakuhin Recent Developments/Updates
  • 6.16 Wockhardt
    • 6.16.1 Wockhardt Corporation Information
    • 6.16.2 Wockhardt Aciclovir Description and Business Overview
    • 6.16.3 Wockhardt Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Wockhardt Product Portfolio
    • 6.16.5 Wockhardt Recent Developments/Updates
  • 6.17 Takata Pharmaceutical
    • 6.17.1 Takata Pharmaceutical Corporation Information
    • 6.17.2 Takata Pharmaceutical Aciclovir Description and Business Overview
    • 6.17.3 Takata Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Takata Pharmaceutical Product Portfolio
    • 6.17.5 Takata Pharmaceutical Recent Developments/Updates
  • 6.18 Aliud
    • 6.18.1 Aliud Corporation Information
    • 6.18.2 Aliud Aciclovir Description and Business Overview
    • 6.18.3 Aliud Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Aliud Product Portfolio
    • 6.18.5 Aliud Recent Developments/Updates
  • 6.19 Amneal Pharma
    • 6.19.1 Amneal Pharma Corporation Information
    • 6.19.2 Amneal Pharma Aciclovir Description and Business Overview
    • 6.19.3 Amneal Pharma Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Amneal Pharma Product Portfolio
    • 6.19.5 Amneal Pharma Recent Developments/Updates
  • 6.20 Apotex
    • 6.20.1 Apotex Corporation Information
    • 6.20.2 Apotex Aciclovir Description and Business Overview
    • 6.20.3 Apotex Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Apotex Product Portfolio
    • 6.20.5 Apotex Recent Developments/Updates
  • 6.21 Arrow
    • 6.21.1 Arrow Corporation Information
    • 6.21.2 Arrow Aciclovir Description and Business Overview
    • 6.21.3 Arrow Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Arrow Product Portfolio
    • 6.21.5 Arrow Recent Developments/Updates
  • 6.22 Laboratoires Servier
    • 6.22.1 Laboratoires Servier Corporation Information
    • 6.22.2 Laboratoires Servier Aciclovir Description and Business Overview
    • 6.22.3 Laboratoires Servier Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Laboratoires Servier Product Portfolio
    • 6.22.5 Laboratoires Servier Recent Developments/Updates
  • 6.23 Sanofi
    • 6.23.1 Sanofi Corporation Information
    • 6.23.2 Sanofi Aciclovir Description and Business Overview
    • 6.23.3 Sanofi Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 Sanofi Product Portfolio
    • 6.23.5 Sanofi Recent Developments/Updates
  • 6.24 Mylan
    • 6.24.1 Mylan Corporation Information
    • 6.24.2 Mylan Aciclovir Description and Business Overview
    • 6.24.3 Mylan Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.24.4 Mylan Product Portfolio
    • 6.24.5 Mylan Recent Developments/Updates
  • 6.25 Orion Pharma
    • 6.25.1 Orion Pharma Corporation Information
    • 6.25.2 Orion Pharma Aciclovir Description and Business Overview
    • 6.25.3 Orion Pharma Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.25.4 Orion Pharma Product Portfolio
    • 6.25.5 Orion Pharma Recent Developments/Updates
  • 6.26 Pfizer
    • 6.26.1 Pfizer Corporation Information
    • 6.26.2 Pfizer Aciclovir Description and Business Overview
    • 6.26.3 Pfizer Aciclovir Sales, Revenue and Gross Margin (2016-2021)
    • 6.26.4 Pfizer Product Portfolio
    • 6.26.5 Pfizer Recent Developments/Updates

7 Aciclovir Manufacturing Cost Analysis

  • 7.1 Aciclovir Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Aciclovir
  • 7.4 Aciclovir Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Aciclovir Distributors List
  • 8.3 Aciclovir Customers

9 Aciclovir Market Dynamics

  • 9.1 Aciclovir Industry Trends
  • 9.2 Aciclovir Growth Drivers
  • 9.3 Aciclovir Market Challenges
  • 9.4 Aciclovir Market Restraints

10 Global Market Forecast

  • 10.1 Aciclovir Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Aciclovir by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Aciclovir by Type (2022-2027)
  • 10.2 Aciclovir Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Aciclovir by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Aciclovir by Application (2022-2027)
  • 10.3 Aciclovir Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Aciclovir by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Aciclovir by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Generic
    Patent

    Segment by Application
    Hospital
    Drug Store

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Greater Pharma
    LBS Labs
    GlaxoSmithKline
    Lex Ano
    Salutas
    Novartis
    Teva
    Stada Nordic
    Cimed Industria de Medicamentos
    Reman Drug
    L.E.T.I.
    Nichi-Iko Pharmaceutical
    Choseido Pharmaceutical
    Shiono Kemikaru
    Towa Yakuhin
    Wockhardt
    Takata Pharmaceutical
    Aliud
    Amneal Pharma
    Apotex
    Arrow
    Laboratoires Servier
    Sanofi
    Mylan
    Orion Pharma
    Pfizer


    Summary:
    Get latest Market Research Reports on Aciclovir. Industry analysis & Market Report on Aciclovir is a syndicated market report, published as Global Aciclovir Market Research Report 2021. It is complete Research Study and Industry Analysis of Aciclovir market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,079.16
    3,118.75
    4,158.33
    2,408.80
    3,613.21
    4,817.61
    313,655.30
    470,482.95
    627,310.60
    218,550.96
    327,826.44
    437,101.92
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report